PATENT CLAIM ANALYSIS

Application Number: 16288630
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "093400"]

Abstract:
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.

Claim (Index 20):
The kit of  claim 19 , wherein the at least one strain of  Roseomonas mucosa  is isolated from a region of the skin of the donor subject which does not comprise eczema.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 99.0
- Lexical Diversity: 1.32353
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16249721', '16271577', '15939066', '16042939', '16271552']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7392520594138178
- 35 USC 102 Novelty (BERT): 0.5533066613805322
- Combined Prediction Score: 0.7206575196104893
- Mean Citation Score: 379.75132
- Max Citation Score: 406.46356
- Similarity Product: 318.03553106354474

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test